• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青少年皮肌炎诱发脂肪萎缩性糖尿病病例。

Case of lipoatrophic diabetes induced by juvenile dermatomyositis.

作者信息

Baba Yusuke, Kaneko Hiyori, Takemoto Minoru, Ide Kana, Haga Yuki, Kanda Tatsuo, Akita Shinsuke, Kubota Yoshitaka, Kuroda Masayuki, Kitagawa Yutaka, Yokote Koutaro

机构信息

Department of Clinical Cell Biology and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.

Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, International University of Health and Welfare, Narita, Japan.

出版信息

J Diabetes Investig. 2017 Sep 12;9(3):632-5. doi: 10.1111/jdi.12745.

DOI:10.1111/jdi.12745
PMID:28895299
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5934268/
Abstract

Lipodystrophy is a rare condition that is often accompanied by one or more metabolic diseases. Here, we report a case of lipoatrophic diabetes induced by juvenile dermatomyositis. Although pioglitazone was not effective for lowering blood glucose levels, our observation suggested that it improved liver function slightly. The effectiveness of metreleptin for lowering blood glucose levels could not be determined, as we administered it in a short period. Liver biopsy showed burned-out non-alcoholic steatohepatitis. The present results show that the successful treatment of lipoatrophic diabetes induced by juvenile dermatomyositis requires an early diagnosis and therapeutic intervention.

摘要

脂肪营养不良是一种罕见的病症,常伴有一种或多种代谢性疾病。在此,我们报告一例由幼年皮肌炎诱发的脂肪萎缩性糖尿病病例。尽管吡格列酮对降低血糖水平无效,但我们的观察表明它能轻微改善肝功能。由于我们使用米泊美生的时间较短,因此无法确定其降低血糖水平的有效性。肝脏活检显示为终末期非酒精性脂肪性肝炎。目前的结果表明,成功治疗由幼年皮肌炎诱发的脂肪萎缩性糖尿病需要早期诊断和治疗干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92a/5934268/da44be64a206/JDI-9-632-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92a/5934268/f0655f3b6487/JDI-9-632-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92a/5934268/da44be64a206/JDI-9-632-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92a/5934268/f0655f3b6487/JDI-9-632-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92a/5934268/da44be64a206/JDI-9-632-g002.jpg

相似文献

1
Case of lipoatrophic diabetes induced by juvenile dermatomyositis.青少年皮肌炎诱发脂肪萎缩性糖尿病病例。
J Diabetes Investig. 2017 Sep 12;9(3):632-5. doi: 10.1111/jdi.12745.
2
The complicated clinical course in a case of atypical lipodystrophy after development of neutralizing antibody to metreleptin: treatment with setmelanotide.在对米替肽产生中和抗体后出现非典型脂肪营养不良病例的复杂临床过程:司美鲁肽治疗
Endocrinol Diabetes Metab Case Rep. 2020 Mar 25;2020. doi: 10.1530/EDM-19-0139.
3
Lipodystrophy in patients with juvenile dermatomyositis--evaluation of clinical and metabolic abnormalities.青少年皮肌炎患者的脂肪营养不良——临床和代谢异常评估
J Rheumatol. 2001 Mar;28(3):610-5.
4
Case Report: Metreleptin and SGLT2 Inhibitor Combination Therapy Is Effective for Acquired Incomplete Lipodystrophy.病例报告:米雷替肽与 SGLT2 抑制剂联合治疗对获得性不完全性脂肪营养不良有效。
Front Endocrinol (Lausanne). 2021 May 31;12:690996. doi: 10.3389/fendo.2021.690996. eCollection 2021.
5
Leptin replacement improves postprandial glycemia and insulin sensitivity in human immunodeficiency virus-infected lipoatrophic men treated with pioglitazone: a pilot study.在接受吡格列酮治疗的人免疫缺陷病毒感染性脂肪萎缩男性中,瘦素替代治疗可改善餐后血糖和胰岛素敏感性:一项初步研究。
Metabolism. 2011 Jul;60(7):1045-9. doi: 10.1016/j.metabol.2010.10.002. Epub 2010 Nov 16.
6
Pioglitazone therapy for HIV/HAART-associated lipodystrophy syndrome could increase subcutaneous fat mass in non-lipoatrophic but not in lipoatrophic regions.吡格列酮治疗HIV/高效抗逆转录病毒治疗相关脂肪代谢障碍综合征可增加非脂肪萎缩区域的皮下脂肪量,但对脂肪萎缩区域无效。
BMJ Case Rep. 2016 Feb 25;2016:bcr2015213637. doi: 10.1136/bcr-2015-213637.
7
Effects of Metreleptin in Pediatric Patients With Lipodystrophy.美曲普明对小儿脂肪营养不良患者的影响。
J Clin Endocrinol Metab. 2017 May 1;102(5):1511-1519. doi: 10.1210/jc.2016-3628.
8
A Report of Three Cases With Acquired Generalized Lipodystrophy With Distinct Autoimmune Conditions Treated With Metreleptin.三例获得性全身性脂肪营养不良合并不同自身免疫性疾病患者接受米泊美生治疗的报告。
J Clin Endocrinol Metab. 2015 Nov;100(11):3967-70. doi: 10.1210/jc.2015-2589. Epub 2015 Sep 21.
9
Congenital generalized lipodystrophy and experimental lipoatrophic diabetes in rabbits treated successfully with fenfluramine.使用芬氟拉明成功治疗的先天性全身性脂肪营养不良和实验性兔脂肪萎缩性糖尿病。
Acta Endocrinol (Copenh). 1977 Jun;85(2):436-48. doi: 10.1530/acta.0.0850436.
10
Partial lipodystrophy associated with juvenile dermatomyositis: report of two cases.与青少年皮肌炎相关的部分脂肪营养不良:两例报告。
Pediatr Dermatol. 1996 Nov-Dec;13(6):477-82. doi: 10.1111/j.1525-1470.1996.tb00728.x.

引用本文的文献

1
SGLT2 inhibitors for genetic and acquired insulin resistance: Considerations for clinical use.SGLT2 抑制剂治疗遗传和获得性胰岛素抵抗:临床应用的注意事项。
J Diabetes Investig. 2020 Nov;11(6):1431-1433. doi: 10.1111/jdi.13309. Epub 2020 Jul 1.

本文引用的文献

1
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized Trial.吡格列酮长期治疗非酒精性脂肪性肝炎伴糖尿病前期或 2 型糖尿病患者的随机试验。
Ann Intern Med. 2016 Sep 6;165(5):305-15. doi: 10.7326/M15-1774. Epub 2016 Jun 21.
2
A Report of Three Cases With Acquired Generalized Lipodystrophy With Distinct Autoimmune Conditions Treated With Metreleptin.三例获得性全身性脂肪营养不良合并不同自身免疫性疾病患者接受米泊美生治疗的报告。
J Clin Endocrinol Metab. 2015 Nov;100(11):3967-70. doi: 10.1210/jc.2015-2589. Epub 2015 Sep 21.
3
The liver diseases of lipodystrophy: the long-term effect of leptin treatment.
脂代谢障碍性肝病:瘦素治疗的长期影响。
J Hepatol. 2013 Jul;59(1):131-7. doi: 10.1016/j.jhep.2013.02.007. Epub 2013 Feb 21.
4
Prolonged thiazolidinedione therapy does not reverse fat loss in patients with familial partial lipodystrophy, Dunnigan variety.
Diabetes Obes Metab. 2008 Dec;10(12):1275-6. doi: 10.1111/j.1463-1326.2008.00978.x.
5
Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity.青少年皮肌炎中获得性脂肪营养不良的预测因素及严重程度梯度
Medicine (Baltimore). 2008 Mar;87(2):70-86. doi: 10.1097/MD.0b013e31816bc604.
6
Efficacy and safety of pioglitazone in treatment of a patient with an atypical partial lipodystrophy syndrome.
Endocr Pract. 2007 Oct;13(6):656-61. doi: 10.4158/EP.13.6.656.
7
Acquired and inherited lipodystrophies.获得性和遗传性脂肪营养不良。
N Engl J Med. 2004 Mar 18;350(12):1220-34. doi: 10.1056/NEJMra025261.
8
Leptin-replacement therapy for lipodystrophy.用于脂肪营养不良的瘦素替代疗法。
N Engl J Med. 2002 Feb 21;346(8):570-8. doi: 10.1056/NEJMoa012437.
9
Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.隐源性肝硬化与移植后非酒精性脂肪性肝病
Liver Transpl. 2001 Sep;7(9):797-801. doi: 10.1053/jlts.2001.24644.
10
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.非酒精性脂肪性肝病:临床和病理严重程度的一个谱系
Gastroenterology. 1999 Jun;116(6):1413-9. doi: 10.1016/s0016-5085(99)70506-8.